Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study.
about
The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular eventsExtracellular Vesicle-Associated Aβ Mediates Trans-Neuronal Bioenergetic and Ca2+-Handling Deficits in Alzheimer's Disease Models.Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer's DiseaseConflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer's disease.Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of Aβ40 and lower ratios of Aβ42/40.Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis.Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid.Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.Interplay between protein glycosylation pathways in Alzheimer's disease.Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.Cross-seeding between Aβ40 and Aβ42 in Alzheimer's disease.Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by α- and β-secretases: relevance to Alzheimer's disease.Fluid biomarker agreement and interrelation in dementia due to Alzheimer's disease.Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.Reproducibility of Alzheimer's Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions.Neurodegenerative disease biomarkers Aβ1-40, Aβ1-42, tau, and p-tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy.Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio.Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairment.The Past and the Future of Alzheimer's Disease Fluid Biomarkers.Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale.Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.
P2860
Q26781635-0D8D8547-65FF-46AF-9819-B62C807792FEQ30830788-AE444B65-9C6F-443E-8838-844A1225FBF3Q36322982-75299C3A-73A8-418B-A6D7-B1570BFFB278Q37487835-72301922-5CD7-41A3-B8F7-4448CD6E2570Q37494841-BD9548E8-4E97-4118-8294-3D26DA629206Q38825497-15F5BEE2-5FA5-4CF4-9EB3-8119C158C374Q39098473-AFFAF3A3-E06C-4D45-B8E2-9CECA76C355EQ39195180-C16FE106-8C8E-4B92-B373-93596C909F39Q39217840-64C37CAD-7A7A-4E28-8570-6A3DBFECA36CQ39451605-C6ABF684-3733-47BF-A58B-B4C2728E83ABQ41723383-1E8E420E-DB39-4D3C-81DB-35F58EF58B3BQ42374123-720AF4CA-FECA-4885-B268-EA60569010BAQ44369500-4FF82D5A-52DB-4017-9DA6-D457D111053AQ47391212-309AA3D2-4BEF-4156-805A-AAE002132EBAQ47573970-AAFB11EC-4CDF-4DF2-817C-97C38061529FQ47976273-84FAD8A1-ADB6-46E5-9EF5-EB136148FB7AQ50034469-1818996B-6E2E-4752-828B-6876841157CFQ50349550-C327EEDF-E1DA-4382-A8F1-C1FF22394E61Q50711684-4935F9F1-4E76-49E7-BF32-99384CC7F3D0Q51737722-7B837C25-8A77-4648-A20D-250B96F41382Q52644601-0743FBFF-AF3F-4D7C-8A94-E8018438D18EQ53430039-28BE9C2E-C511-4C5A-B310-03DA22657E3CQ54960062-AFF5BF46-5AE6-4874-A2C6-45136B1569C5Q55383590-E30C94F5-F35A-41FD-A4F7-C9339EB1B76D
P2860
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cerebrospinal fluid amyloid-β ...... centers: a multicentric study.
@ast
Cerebrospinal fluid amyloid-β ...... centers: a multicentric study.
@en
type
label
Cerebrospinal fluid amyloid-β ...... centers: a multicentric study.
@ast
Cerebrospinal fluid amyloid-β ...... centers: a multicentric study.
@en
prefLabel
Cerebrospinal fluid amyloid-β ...... centers: a multicentric study.
@ast
Cerebrospinal fluid amyloid-β ...... centers: a multicentric study.
@en
P2093
P2860
P50
P1476
Cerebrospinal fluid amyloid-β ...... centers: a multicentric study.
@en
P2093
Claire Paquet
Jacques Hugon
Jacques Touchon
Jean-Louis Laplanche
Ksenia V Kastanenka
Olivier Vercruysse
Stéphanie Bombois
Susanna Schraen
Sylvain Lehmann
P2860
P2888
P356
10.1186/S13195-015-0114-5
P407
P577
2015-06-01T00:00:00Z
P5875
P6179
1040421883